Medicare Enrolled
Dr. Reynolds Delgado, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Delgado from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delgado?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delgado
Dr. Reynolds Delgado is a cardiovascular disease specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Delgado performed 4,450 Medicare services across 1,620 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delgado received a total of $475,349 from 59 pharmaceutical and/or device companies across 1417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delgado is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in TX
$475,349 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,450
Medicare services
Top 21% in TX for cardiovascular disease
1,620
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~234 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,662 | $0 | $4 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
332 | $39 | $128 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
331 | $40 | $128 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
320 | $12 | $76 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
272 | $155 | $1,250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
254 | $97 | $205 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
208 | $64 | $137 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $42 | $69 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
161 | $71 | $133 |
| Evaluation of lower heart chamber assist device Assessment of the function and status of a device that assists the lower chambers of the heart. |
100 | $32 | $145 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
96 | $96 | $195 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $69 | $133 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
72 | $51 | $266 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
58 | $355 | $2,000 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
58 | $89 | $114 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $140 | $385 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
28 | $9 | $14 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
28 | $43 | $96 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $125 | $342 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
24 | $41 | $64 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $46 | $96 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
21 | $20 | $240 |
| Cardiac catheterization | 21 | $428 | $8,002 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $151 | $600 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
13 | $1,009 | $3,395 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 13 | $582 | $852 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $287 | $1,508 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.6% high complexity
46.8% medium
46.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$475,349
Total received (2018-2024)
Avg $67,907/year across 7 years
Top 1% in TX for cardiovascular disease
59
Companies
1,417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$454,783 (95.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,678 (3.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,888 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$59,604
2023
$92,158
2022
$68,667
2021
$58,539
2020
$45,833
2019
$101,175
2018
$49,373
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$129,817
Akcea Therapeutics, Inc.
$70,335
Novartis Pharmaceuticals Corporation
$54,524
Merck Sharp & Dohme LLC
$48,749
AstraZeneca Pharmaceuticals LP
$46,178
Janssen Pharmaceuticals, Inc
$43,495
PFIZER INC.
$27,401
Lilly USA, LLC
$21,032
Bayer HealthCare Pharmaceuticals Inc.
$9,608
Bayer Healthcare Pharmaceuticals Inc.
$4,530
Abbott Laboratories
$3,926
Adagio Medical, Inc.
$2,888
Pfizer Inc.
$2,625
Biosense Webster, Inc.
$1,657
E.R. Squibb & Sons, L.L.C.
$1,114
Impulse Dynamics (USA) Inc.
$969
Amgen Inc.
$717
Medtronic Vascular, Inc.
$580
SANOFI-AVENTIS U.S. LLC
$530
Alnylam Pharmaceuticals Inc.
$475
Actelion Pharmaceuticals US, Inc.
$456
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$421
Esperion Therapeutics, Inc.
$313
ABIOMED
$302
Otsuka America Pharmaceutical, Inc.
$259
CVRx, Inc.
$223
Amarin Pharma Inc.
$220
BOSTON SCIENTIFIC CORPORATION
$206
Medtronic, Inc.
$178
Lexicon Pharmaceuticals, Inc.
$160
ATRICURE, INC.
$159
CARDIVA MEDICAL, INC.
$155
Boston Scientific Corporation
$99
GENZYME CORPORATION
$97
HeartFlow, Inc.
$88
Daiichi Sankyo Inc.
$87
Janssen Scientific Affairs, LLC
$79
Novo Nordisk Inc
$75
Lundbeck LLC
$69
Gilead Sciences, Inc.
$50
G Medical Diagnostic Services, Inc.
$48
Itamar Medical Inc
$47
HEARTFLOW, INC.
$46
Bardy Diagnostics, Inc.
$37
Kestra Medical Technology Services, Inc.
$34
AGEPHA Pharma FZ LLC
$29
Tactile Systems Technology Inc
$27
AngioDynamics, Inc.
$27
SCPHARMACEUTICALS INC.
$27
AltaThera Pharmaceuticals LLC
$24
Kiniksa Pharmaceuticals, Ltd.
$24
Kiniksa Pharmaceuticals International, plc
$20
Inspire Medical Systems, Inc.
$19
BIOTRONIK INC.
$18
ARGON MEDICAL DEVICES, INC.
$18
Sobi, Inc
$18
Aziyo Biologics, Inc.
$14
Allergan Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 53.6% of total payments
Associated products mentioned in payments ›
AVEIR · Adempas · Advisa · AngioVac · Arcalyst · Assure WCD · Attain · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CRM-Research only · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Cartomerge · Circulatory Support · Cobalt · Corlanor · ECM · ELIQUIS · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbyclor · Ensite Cardiac Mapping System · FABRAZYME · FARXIGA · FFRct · FORTIFY ASSURA · FUROSCIX · Flexitouch Plus · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate II LVAS · HeartMate Touch · HeartWare HVAD · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · JYNARQUE · Kerendia · LODOCO · LifeVest · MICRA · MULTAQ · MYCARELINK · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · OPTION · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · RHYTHMIA · Repatha · Reveal LINQ · Rhythmia Mapping System · SAMSCA · Sotalol Hydrochloride · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · Verquvo · Visitag · WAINUA · WATCHMAN · WATCHMAN Access System · WatchPAT · XARELTO · iCLAS Continuous Lesion Ablation System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in TX.
Equivalent to $10,682 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Delgado is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Delgado experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Delgado performed 1,662 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delgado receive payments from pharmaceutical companies?
Yes. Dr. Delgado received a total of $475,349 from 59 companies across 1,417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delgado's costs compare to other cardiologists in Houston?
Dr. Delgado's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delgado) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Akcea Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Akcea Therapeutics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology